Study for people with severe emphysema and limited lung collateral airflow
Part of Lungs & breathing clinical trials.
This registry study follows adults with severe emphysema who have shortness of breath and low natural “backup” airflow between parts of the lung. It may help better understand how a specific FDA-approved treatment works for the right patients over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 or older).
- You have shortness of breath and severe emphysema (lung air sacs are damaged).
- Your breathing tests/showing scans suggest low collateral ventilation (little natural backup airflow between lung areas).
- You can understand the study and sign consent of your own free will.
- You must be a candidate for SVS therapy based on the FDA-approved instructions for use.
- You must have complete screening and baseline information, and you cannot have been previously withdrawn from this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a small silicone valve placed in your airways to help you breathe better if you have emphysema. It may be an option if you have severe breathing problems and are not getting enough relief from medicine alone.
This study compares two ways to reduce lung “overinflation” in people with severe emphysema: surgery (LVRS) or a bronchoscopy procedure (BLVR). It aims to see which approach works best and is safest for eligible patients.
This study tests whether placing tiny valves in the airways can help people with severe COPD breathe easier. It is for people who still have trouble breathing despite quitting smoking and completing pulmonary rehab.
This study is tracking the real-world use of the Zephyr Valve, a device that helps people with severe COPD breathe easier. It will check if the valve is safe and works well for people in Japan who have been chosen for this treatment by their doctor.
This study tests a bronchoscopic treatment to release trapped air in severely hyperinflated lungs caused by emphysema. It may help you breathe easier if you have advanced COPD and meet specific lung function and imaging criteria.
This trial tests an implantable artificial bronchus to help people with severe emphysema breathe easier. It's for those who have stable COPD, can walk 100–400 meters in 6 minutes, and haven't smoked for at least 4 months.
Hear when a new Emphysema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.